EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Sequential treatment with nusinersen, Zolgensma® and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case report.

Ilaria Bitetti, Maria Rosaria Manna, Roberto Stella, Antonio Varone

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · 01.01.2023 · 42 (2-3) · 82-85

DOI: 10.36185/2532-1900-356 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, erschienen am 01.01.2023. Verfasst von Ilaria Bitetti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology, Santobono-Pausilipon Children's Hospital, Naples, Italy. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Spinal Muscular Atrophies of Childhood. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

due to caregiver's decision. In the months following the administration, the patient showed significant clinical improvement in motor performance. After 12 months, the child started therapy with risdiplam in another country. One year after the start of therapy with risdiplam further improvements in both motor and bulbar functions were highlighted. This case report raises a question: is a multiple consecutive theraphy more effective than monotherapy in SMA treatment? These results suggest the need to further explore the potential efficacy of a multidrug treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalSpinal Muscular Atrophies of ChildhoodFemaleChildHumansInfantOligonucleotidesBiological ProductsRecombinant Fusion ProteinsAzo CompoundsPyrimidines

Stichwörter der Autor:innen

abeparvovecgene replacement therapyneurocognitive functionnusinersenona semnogenerisdiplamspinal muscular atrophy

Substanzen

OligonucleotidesnusinersenZolgensmaBiological ProductsRecombinant Fusion ProteinsRisdiplamAzo CompoundsPyrimidines

Autor:innen und Institutionen

  • Pediatric Neurology, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Rehabilitation Unit, Santobono-Pausilipon Children's Hospital, Naples, Italy.

Zitieren

APA

Bitetti, I., Manna, M. R., Stella, R., & Varone, A. (2023). Sequential treatment with nusinersen, Zolgensma® and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case report. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, 42(2-3), 82-85. https://doi.org/10.36185/2532-1900-356

Vancouver

Bitetti I, Manna MR, Stella R, Varone A. Sequential treatment with nusinersen, Zolgensma® and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case report. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases. 2023;42(2-3):82-85. doi:10.36185/2532-1900-356

BibTeX
@article{Bitetti2023,
  author = {Bitetti, Ilaria and Manna, Maria Rosaria and Stella, Roberto and Varone, Antonio},
  title = {Sequential treatment with nusinersen, Zolgensma® and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case report},
  journal = {Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases},
  year = {2023},
  volume = {42},
  number = {2-3},
  pages = {82--85},
  doi = {10.36185/2532-1900-356}
}
Kostenlos starten →